{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:46Z","timestamp":1786119526815,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/jcp.0b013e318205e66d","type":"journal-article","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T05:39:24Z","timestamp":1293687564000},"page":"98-102","source":"Crossref","is-referenced-by-count":18,"title":["Antidepressant Drugs in Children and Adolescents"],"prefix":"10.1097","volume":"31","author":[{"given":"Maria D.","family":"Cherm\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ahlner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per A.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1192\/bjp.184.5.386","article-title":"Global burden of depressive disorders in the year 2000.","volume":"184","author":"Ustun","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R2-18-20210128","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpsyc.1996.01830120067012","article-title":"The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders.","volume":"53","author":"Costello","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"R4-18-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1034\/j.1600-0447.2001.00170.x","article-title":"Forty years of antidepressant drug trials.","volume":"104","author":"Barbui","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"R5-18-20210128","first-page":"2592","article-title":"Kraftig okning av antidepressiva lakemedel till barn och ungdomar. Nya mediciner bidrar starkt till stigande lakemedelskostnader.","volume":"97","author":"Ahlgren","year":"2000","journal-title":"Lakartidningen"},{"key":"R7-18-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00007691-200404000-00010","article-title":"Therapeutic drug monitoring of psychotropic drugs. TDM \"nouveau\".","volume":"26","author":"Bengtsson","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R8-18-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007691-200208000-00014","article-title":"Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.","volume":"24","author":"Reis","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R9-18-20210128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007691-200008000-00014","article-title":"Therapeutic drug monitoring of sertraline: variability factors as displayed in a clinical setting.","volume":"22","author":"Lundmark","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R10-18-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.31887\/DCNS.2005.7.3\/pbaumann","article-title":"The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.","volume":"7","author":"Baumann","year":"2005","journal-title":"Dialogues Clin Neurosci"},{"key":"R11-18-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-2004-832687","article-title":"The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.","volume":"37","author":"Baumann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"R12-18-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00007691-200304000-00007","article-title":"Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997.","volume":"25","author":"Reis","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R13-18-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ftd.0000158873.54100.d4","article-title":"Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study.","volume":"27","author":"Reis","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R14-18-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.599","article-title":"Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.","volume":"19","author":"Reis","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"R15-18-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-200104000-00008","article-title":"Serum concentrations of fluoxetine in the clinical treatment setting.","volume":"23","author":"Lundmark","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R16-18-20210128","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R17-18-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0378-4347(97)00366-6","article-title":"Solid-phase extraction with end-capped C2 columns for the routine measurement of racemic citalopram and metabolites in plasma by high-performance liquid chromatography.","volume":"702","author":"Carlsson","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R18-18-20210128","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00007691-200112000-00011","article-title":"Enantioselective analysis of citalopram and metabolites in adolescents.","volume":"23","author":"Carlsson","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R19-18-20210128","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/S0924-977X(97)88462-3","article-title":"A simple method for routine TDM of the SSRI sertraline and desmethylsertraline in serum by HPLC.","volume":"7","author":"Bjork","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"R20-18-20210128","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00228-003-0654-7","article-title":"Identification of CYP2D6 alleles by single nucleotide polymorphism analysis using pyrosequencing.","volume":"59","author":"Zackrisson","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"R21-18-20210128","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1373\/clinchem.2004.043182","article-title":"Determination of CYP2D6 gene copy number by pyrosequencing.","volume":"51","author":"Soderback","year":"2005","journal-title":"Clin Chem"},{"key":"R23-18-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","article-title":"Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database.","volume":"31","author":"Reis","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R24-18-20210128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00004583-199804000-00016","article-title":"Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.","volume":"37","author":"Alderman","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R25-18-20210128","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.chi.0000138356.29099.f1","article-title":"Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.","volume":"43","author":"Geller","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R26-18-20210128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00004583-200108000-00010","article-title":"Long-term experience with citalopram in the treatment of adolescent OCD.","volume":"40","author":"Thomsen","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R27-18-20210128","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/FTD.0b013e31815b3f62","article-title":"Therapeutic drug monitoring of escitalopram in an outpatient setting.","volume":"29","author":"Reis","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R28-18-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/JCP.0b013e31817d79eb","article-title":"Assessment of the prescription of antidepressant drugs in elderly nursing home patients: a clinical and laboratory follow-up investigation.","volume":"28","author":"Cherma","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R29-18-20210128","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/clpt.2009.216","article-title":"High frequency of occurrence of CYP2D6 gene duplication\/multiduplication indicating ultrarapid metabolism among suicide cases.","volume":"88","author":"Zackrisson","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R30-18-20210128","first-page":"44","article-title":"Prescribing for unlabeled indications.","volume":"7","author":"Serradell","year":"1993","journal-title":"HMO Pract"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JCP.0b013e318205e66d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:08Z","timestamp":1786041908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201102000-00018"}},"subtitle":["Analytical and Demographic Data in a Naturalistic, Clinical Study"],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318205e66d","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}